July 29, 2019
Mark Farber, MD, chief of vascular surgery at the UNC School of Medicine, is the national principal investigator for the study and performed the trial’s first implant of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis, an investigational device, at UNC Hospitals in Chapel Hill, NC.
July 22, 2019
The departments of psychiatry and obstetrics and gynecology at the UNC School of Medicine are collaborating on a large-scale, $13.2 million PCORI-funded perinatal psychiatry trial that will also bring together researchers at University of Toronto in Canada and NorthShore University HealthSystem in Chicago.
July 15, 2019
The large-scale genome-wide association study, led by UNC’s Cynthia M. Bulik, PhD, FAED, founding director of the UNC Center of Excellence for Eating Disorders, and Gerome Breen, PhD, of King’s College London suggests that the origins of the eating disorder include a combination of metabolic and psychiatric components.
July 11, 2019
The Office of Faculty Affairs and Leadership Development would like to welcome home Steve Bogdewic, PhD, MA, to the UNC School of Medicine. Dr. Bogdewic returns home from the Indiana University School of Medicine, where he served as Executive Vice Dean, and we are thrilled to have him on board as we continue to expand our team and offerings.
July 10, 2019
Scott Commins, MD, PhD, continues to research “alpha-gal” meat allergy and create awareness for the tick-borne illness as a new CDC research study begins. Recognized as a leading national expert, Commins will now guide a US DHHS Tick-Borne Working Group Subcommittee.
June 12, 2019
Based on the proven benefits of Mediterranean-style diets, researchers have created a unique version of the diet by considering the taste and preferences of people living in the southeastern U.S. With this grant, the “Med-South” diet will be explored as an option for long-term weight loss and improved cardiovascular health. The study is co-led by Thomas Keyserling, MD, MPH, and Carmen Samuel-Hodge, PhD, RD.
May 24, 2019
Adding genomic sequencing results to traditional newborn screening means a baby could potentially test positive for numerous conditions that might not develop within their lifetime. A UNC School of Medicine study proposed a method for how to responsibly determine which types of conditions to include in testing and potentially return to parents.
May 21, 2019
Meltzer-Brody is the recipient of the 2019 Alexandra Symonds Award, given in recognition of outstanding contributions and leadership in promoting women’s health and the advancement of women.
May 10, 2019
UNC School of Medicine’s Samuel Cykert, MD, a member of the UNC Lineberger Comprehensive Cancer Center, co-led a five-year, multi-institutional trial aimed at reducing the disparity in treatment and outcomes for black versus white lung and breast cancer patients.
April 3, 2019
Hearing aids can be an expensive out-of-pocket expense. In an effort to help make hearing health care more accessible, especially to those working in a health care environment, UNC Hospitals is now offering a 15% discount on hearing aids to UNC Hospitals, UNC Faculty Physicians and UNCPN employees. We offer multiple products, styles and brands …
March 21, 2019
UNC participated in three clinical trials for the drug ZULRESSO, developed by Sage Therapeutics. Samantha Meltzer-Brody, MD, MPH, director of the Perinatal Psychiatry Program at the UNC SOM, was the academic principal investigator for the trials, which the FDA reviewed during its approval process for ZULRESSO.
March 20, 2019
ZULRESSO, developed by Sage Therapeutics, is the first and only treatment specifically indicated to treat postpartum depression in women. UNC School of Medicine’s Samantha Meltzer-Brody, MD, MPH, was the principal investigator for three clinical trials showing rapid-reduction in depressive symptoms, and says the approval marks a major step forward in women’s healthcare.